Growth Hormone Gene Deletion

DrugDrug NameDrug Description
DB14751Mecasermin rinfabateMecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) ....
DrugDrug NamePhaseStatusCount